Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 19.35 |
|---|---|
| High | 21.56 |
| Low | 19.16 |
| Bid | 19.94 |
| Offer | 22.48 |
| Previous close | 19.69 |
| Average volume | 202.95k |
|---|---|
| Shares outstanding | 31.07m |
| Free float | 29.07m |
| P/E (TTM) | -- |
| Market cap | 611.70m USD |
| EPS (TTM) | -2.31 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Alto Neuroscience Announces Participation in Upcoming Investor Conferences
- Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
- Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment
- Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
- Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology
- Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
More ▼
